STOCK TITAN

Hyperliquid Strategies Inc (PURR) Financials

PURR
FY2026 annual
Revenue $9.5M YoY not available
Net Income $305.5M YoY not available
EPS (Diluted) $3.21 YoY not available
Operating Cash Flow -$19.1M YoY not available
Market Cap $2.3B as of Sep 11, 2026
Price / Sales 243x on $9.5M revenue, FY2026
Price / Earnings 7.5x on $305.5M net income, FY2026
Price / Book 1.2x on $1.9B equity, Q4 FY2026

A multiple compares the market's price with a filed figure; it says what the market pays, not how the business is doing. The market capitalization is the vendor's as of Sep 11, 2026; every other figure is from the SEC filings on this page. Not financial advice.

Source SEC Filings (10-K/10-Q) Latest period FY2026, ended Jun 30, 2026 Reported Currency USD FYE June

Newest figures come from the 10-K for FY2026, filed Aug 27, 2026. Each column of the statement tables below links to the filing it was taken from, and every filing is listed on the PURR SEC filings page.

Hyperliquid Strategies Inc (PURR) reported $9.5M in revenue for fiscal year 2026. This page shows its income statement, balance sheet, cash flow statement, and key financial ratios. All figures are derived from SEC filings (10-K and 10-Q reports).

Rhea AI PURR FY2026

Reported profitability is disconnected from sales and cash generation, while financing flows support balance-sheet-heavy capital deployment.

FY2026 shows operating income of $500.6M against revenue of only $9.5M, so the reported result is not being driven by ordinary sales economics. Net income of $305.5M alongside operating cash flow of -$19.1M further indicates that accounting earnings did not translate into cash from operations during the period.

The balance sheet is lightly burdened by liabilities: total assets were $2.1B versus total liabilities of $187.1M. A 0.1x debt-to-equity ratio points to an equity-funded structure rather than one dependent on borrowing.

Investing cash flow of -$777.4M occurred alongside financing cash flow of $934.5M, indicating that large capital deployment was accompanied by external funding rather than operating cash generation. The 41.6x current ratio also reflects a substantial short-term asset cushion relative to current obligations.

[ NOT FINANCIAL ADVICE ]

Financial Health Signals

Financial health score not available

Hyperliquid Strategies Inc does not currently provide enough eligible data for a peer-relative financial health score, so none is published. The signals and metrics below are current.

Earnings Quality No Cash Backing

For every $1 of reported earnings, Hyperliquid Strategies Inc used $0.06 of operating cash (-$19.1M OCF vs $305.5M net income). Earnings that no cash stands behind rest on accounting accruals, which cannot be repeated indefinitely.

Key Financial Metrics

Export CSV

Earnings & Revenue

EPS (Diluted)
$6.24
QoQ+517.8%

Hyperliquid Strategies Inc earned $6.24 per diluted share (EPS) in Q4 2026. Against the prior quarter it is up 517.8%.

Revenue

Not reported for Q4 2026.

EBITDA

Not reported for Q4 2026.

Net Income

Not reported for Q4 2026.

Cash & Balance Sheet

Cash & Debt
$137.9M
QoQ+22.0%

Hyperliquid Strategies Inc held $137.9M in cash as of Q4 2026; long-term debt is not reported for that period.

Shares Outstanding
198M
QoQ+47.0%

Hyperliquid Strategies Inc had 198M shares outstanding in Q4 2026. Against the prior quarter it is up 47.0%.

Free Cash Flow

Not reported for Q4 2026.

Dividends Per Share

Not reported for Q4 2026.

Margins & Returns

None of these metrics is reported for Q4 2026.

Capital Allocation

Share Buybacks
$91K
QoQ-92.0%

Hyperliquid Strategies Inc spent $91K on share buybacks in Q4 2026, returning capital to shareholders by reducing shares outstanding. Against the prior quarter it is down 92.0%.

R&D Spending

Not reported for Q4 2026.

Capital Expenditures

Not reported for Q4 2026.

PURR Income Statement

Figures in USD, abbreviated K (thousand), M (million), B (billion), T (trillion). Negative values carry a minus sign and red type. Each change compares the year with the year before it, and each quarter with the same quarter a year earlier.

PURR quarterly income statement
MetricQ4'2610-KQ3'26S-1/AQ2'2610-QQ1'26S-1/AQ4'2510-K
RevenueN/A$2.6M$500KN/AN/A
Operating IncomeN/A$193.8M-$287.5MN/AN/A
Income TaxN/A$42.7M$17.8MN/AN/A
Net IncomeN/A$152.5M-$304.5M-$13.4MN/A
EPS (Basic)$6.24$1.01-$7.43-$13183.92N/A
EPS (Diluted)$6.24$1.01-$7.43-$13183.92N/A
Diluted Shares (Avg)N/A124M41M92N/A

Not reported in any period shown, so not listed: Cost of Revenue, Gross Profit, R&D Expenses, SG&A Expenses, EBITDA, Interest Expense.

PURR Balance Sheet

Figures in USD, abbreviated K (thousand), M (million), B (billion), T (trillion). Negative values carry a minus sign and red type. Each change compares the year with the year before it, and each quarter with the same quarter a year earlier.

PURR quarterly balance sheet
MetricQ4'2610-KQ3'26S-1/AQ2'2610-QQ1'26S-1/AQ4'2510-K
Total Assets$2.1B$810.4M$616.6M-$12.5M$0
Current Assets$152.4M$117.4M$287.1MN/A$0
Cash & Equivalents$137.9M$113.1M$281.9MN/A$0
Short-Term Investments$0$0$0N/A$0
Long-Term Investments$0$0$0N/A$0
Goodwill$0$0$0N/AN/A
Total Liabilities$187.1M+31246.2%$66.9M$26.9M$1.2M$597K
Current Liabilities$3.7M+513.4%$6.4M$9.1MN/A$597K
Non-Current Liabilities$183.5M$60.5M$17.8MN/A$0
Total Equity$1.9B+313813.7%$743.5M$589.8M-$13.7M-$597K
Retained Earnings$304.9M+51179.6%-$165.9M-$318.5M-$1.2M-$597K

Not reported in any period shown, so not listed: Inventory, Accounts Receivable, Long-Term Debt.

PURR Cash Flow Statement

Figures in USD, abbreviated K (thousand), M (million), B (billion), T (trillion). Negative values carry a minus sign and red type. Each change compares the year with the year before it, and each quarter with the same quarter a year earlier.

PURR quarterly cash flow statement
MetricQ4'2610-KQ3'26S-1/AQ2'2610-QQ1'26S-1/AQ4'2510-K
Operating Cash Flow-$3.8M-$7.0MN/A$0N/A
Stock-Based CompensationN/A$186KN/AN/AN/A
Investing Cash Flow-$616.6M-$162.2MN/AN/AN/A
Financing Cash Flow$645.3M$332KN/AN/AN/A
Share Buybacks-$91K$1.1MN/AN/AN/A

Not reported in any period shown, so not listed: Depreciation & Amortization, Capital Expenditures, Free Cash Flow, Dividends Paid.

PURR Financial Ratios

Margins and returns are percentages; the remaining ratios are unitless multiples. Each change compares the year with the year before it, and each quarter with the same quarter a year earlier.

PURR quarterly financial ratios
MetricQ4'2610-KQ3'26S-1/AQ2'2610-QQ1'26S-1/AQ4'2510-K
Operating MarginN/A7380.6%-57509.2%N/AN/A
Net MarginN/A5807.7%-60892.6%N/AN/A
Return on EquityN/A20.5%-51.6%N/AN/A
Return on AssetsN/A18.8%-49.4%107.3%N/A
Current Ratio41.62+41.6x18.2231.62N/A0.00
Debt-to-Equity0.100.090.05N/AN/A
Asset TurnoverN/A0.000.00N/AN/A

Not reported in any period shown, so not listed: Gross Margin, FCF Margin.

Reported as filed but not readable as a share of revenue in the periods where the ratio runs further from zero than a revenue base allows; no change figure is given where either compared period is one of those: Operating Margin, Net Margin.

Frequently Asked Questions

What is Hyperliquid Strategies Inc's annual revenue?

Hyperliquid Strategies Inc (PURR) reported $9.5M in total revenue for fiscal year 2026. Revenue measures the total income earned from the company's primary business operations before any expenses are deducted.

Is Hyperliquid Strategies Inc profitable?

Yes, Hyperliquid Strategies Inc (PURR) reported a net income of $305.5M in fiscal year 2026.

What is Hyperliquid Strategies Inc's earnings per share (EPS)?

Hyperliquid Strategies Inc (PURR) reported diluted earnings per share of $3.21 for fiscal year 2026. EPS represents the portion of a company's net income allocated to each outstanding share of common stock and is widely used to evaluate profitability on a per-share basis.

Hyperliquid Strategies Inc (PURR) has a return on equity of 16.3% for fiscal year 2026, measuring how efficiently the company generates profit from shareholder equity.

Hyperliquid Strategies Inc (PURR) recorded an outflow of $19.1M in operating cash flow during fiscal year 2026, representing cash used by core business activities.

Hyperliquid Strategies Inc (PURR) had $2.1B in total assets as of fiscal year 2026, including both current and long-term assets.

Yes, Hyperliquid Strategies Inc (PURR) spent $10.5M on share buybacks during fiscal year 2026, returning capital to shareholders by reducing shares outstanding.

Hyperliquid Strategies Inc (PURR) had 198M shares outstanding as of fiscal year 2026.

Hyperliquid Strategies Inc (PURR) had a current ratio of 41.62 as of fiscal year 2026, which is generally considered healthy.

Hyperliquid Strategies Inc (PURR) had a debt-to-equity ratio of 0.10 as of fiscal year 2026, measuring the company's financial leverage by comparing total debt to shareholder equity.

Hyperliquid Strategies Inc (PURR) had a return on assets of 14.8% for fiscal year 2026, measuring how efficiently the company uses its assets to generate profit.

Hyperliquid Strategies Inc (PURR) trades at 7.5x earnings, its market capitalization divided by net income of $305.5M net income, FY2026. The market capitalization is $2.3B as of Sep 11, 2026; a multiple compares that price with a filed figure and says nothing about the quality of the business.

Hyperliquid Strategies Inc (PURR) trades at 243x sales, its market capitalization divided by revenue of $9.5M revenue, FY2026. The market capitalization is $2.3B as of Sep 11, 2026; a multiple compares that price with a filed figure and says nothing about the quality of the business.

For every $1 of reported earnings, Hyperliquid Strategies Inc (PURR) used $0.06 of operating cash (-$19.1M OCF vs $305.5M net income). Earnings that no cash stands behind rest on accounting accruals, which cannot be repeated indefinitely. This ratio compares operating cash flow to net income. A ratio above 1.0x means the company generates more cash than its reported earnings, indicating sustainable, cash-backed profits. Ratios below 1.0x suggest earnings rely on accounting accruals rather than actual cash generation. Learn more in our complete guide to financial health indicators.

Back to top